Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)

0.4283
Delayed Data
As of May 26
 -0.0117 / -2.66%
Today’s Change
0.42
Today|||52-Week Range
28.11
-69.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$5.1M

Company Description

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Contact Information

Quoin Pharmaceuticals Ltd.
42127 Pleasant Forest Court
Ashburn Virginia 20148
P:(703) 980-4182
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Michael MyersChairman & Chief Executive Officer
Denise CarterChief Operating Officer & Director
Gordon B. DunnChief Financial Officer